Evidence map›Paper›PMID 34471225›Full record

ArticleInternational journal of obesity (2005)2022

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance.

O Contreras-Rodriguez, M Arnoriaga-Rodríguez, R Miranda-Olivos, G Blasco, C Biarnés, J Puig, J Rivera-Pinto, M L Calle, V Pérez-Brocal, A Moya and 4 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

O Contreras-Rodriguez *Department of Psychiatry, Bellvitge University Hospital-IDIBELL, and CIBERSam-17 and CIBERObn (CB06/03/0034), Barcelona, Spain. ocontreras@idibgi.org.ORCID http://orcid.org/0000-0001-8922-8084
M Arnoriaga-Rodríguez *Health Institute Carlos III (ISCIII), Barcelona, Spain.
R Miranda-OlivosDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, and CIBERSam-17 and CIBERObn (CB06/03/0034), Barcelona, Spain.
G BlascoDepartment of Radiology-Medical Imaging (IDI), Girona Biomedical Research Institute (IdIBGi), Josep Trueta University Hospital, Girona, Spain.
C BiarnésDepartment of Radiology-Medical Imaging (IDI), Girona Biomedical Research Institute (IdIBGi), Josep Trueta University Hospital, Girona, Spain.
J PuigDepartment of Radiology-Medical Imaging (IDI), Girona Biomedical Research Institute (IdIBGi), Josep Trueta University Hospital, Girona, Spain.
J Rivera-PintoIrsiCaixa AIDS Research Institute, Badalona, Spain.
M L CalleBiosciences Department, Faculty of Sciences and Technology, University of Vic-Central University of Catalonia, VIC, Badalona, Spain.ORCID http://orcid.org/0000-0001-9334-415X
V Pérez-BrocalDepartment of Genomics and Health, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain, and CIBEResp- CB06/02/0050, Madrid, Spain.
A MoyaDepartment of Genomics and Health, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain, and CIBEResp- CB06/02/0050, Madrid, Spain.ORCID http://orcid.org/0000-0002-2867-1119
C CollNeuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Girona Biomedical Research Institute (IdIBGi), Dr. Josep Trueta University Hospital, Girona, Spain.ORCID http://orcid.org/0000-0003-2927-4008
L Ramió-TorrentàDepartment of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.
C Soriano-MasDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, and CIBERSam-17 and CIBERObn (CB06/03/0034), Barcelona, Spain.ORCID http://orcid.org/0000-0003-4574-6597
J M Fernandez-RealHealth Institute Carlos III (ISCIII), Barcelona, Spain. jmfreal@idibgi.org.ORCID http://orcid.org/0000-0002-7442-9323
Institut d'Investigació Biomèdica de Girona · ESUniversitat de Girona · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESUniversitat Autònoma de Barcelona · ESUniversitat de Vic - Universitat Central de Catalunya · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional connectivity alterations in the lateral and medial hypothalamic networks have been associated with the development and maintenance of obesity, but the possible impact on the structural properties of these networks remains largely unexplored. Also, obesity-related gut dysbiosis may delineate specific hypothalamic alterations within obese conditions. We aim to assess the effects of obesity, and obesity and gut-dysbiosis on the structural covariance differences in hypothalamic networks, executive functioning, and depressive symptoms.

methodsMedial (MH) and lateral (LH) hypothalamic structural covariance alterations were identified in 57 subjects with obesity compared to 47 subjects without obesity. Gut dysbiosis in the subjects with obesity was defined by the presence of high (n = 28) and low (n = 29) values in a BMI-associated microbial signature, and posthoc comparisons between these groups were used as a proxy to explore the role of obesity-related gut dysbiosis on the hypothalamic measurements, executive function, and depressive symptoms.

resultsStructural covariance alterations between the MH and the striatum, lateral prefrontal, cingulate, insula, and temporal cortices are congruent with previously functional connectivity disruptions in obesity conditions. MH structural covariance decreases encompassed postcentral parietal cortices in the subjects with obesity and gut-dysbiosis, but increases with subcortical nuclei involved in the coding food-related hedonic information in the subjects with obesity without gut-dysbiosis. Alterations for the structural covariance of the LH in the subjects with obesity and gut-dysbiosis encompassed increases with frontolimbic networks, but decreases with the lateral orbitofrontal cortex in the subjects with obesity without gut-dysbiosis. Subjects with obesity and gut dysbiosis showed higher executive dysfunction and depressive symptoms.

conclusionsObesity-related gut dysbiosis is linked to specific structural covariance alterations in hypothalamic networks relevant to the integration of somatic-visceral information, and emotion regulation.

Indexed as

AdultBody Mass IndexCross-Sectional StudiesDysbiosisFemaleHumansHypothalamic DiseasesHypothalamusMaleMiddle AgedNeural PathwaysObesity

Identifiers

PMID34471225
PMCPMC8748191
OpenAlexW3198417212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.